Model for End-Stage Liver Disease (MELD) exception for familial amyloidotic polyneuropathy

Liver Transplantation

Volumn 12, Issue 12 SUPPL. 3, 2006, Pages

  Pomfret, Elizabeth ^a   Gish, Robert G ^b   Brandhagen, David ^c  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PROTEIN; METHIONINE; PREALBUMIN; VALINE;

ARTICLE; CARDIOVASCULAR RISK; CHRONIC LIVER DISEASE; FAMILIAL AMYLOID POLYNEUROPATHY; GENE MUTATION; GRAFT RECIPIENT; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME;

AMYLOID NEUROPATHIES, FAMILIAL; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; PREALBUMIN; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT;

EID: 33845501648     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20962     Document Type: Article

References (11)

1. Lobato L. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M). J Nephrol 2003;16:438-442.
2. Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000;6:263-276.
3. Herlenius G, Wilczek HE, Larsson M, Ericzon BG, Familial Amyloidotic Polyneuropathy World Transplant Registry. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 2004;77:64-71.
4. Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991;40:242-246.
5. Familial Amyloidotic Polyneuropathy World Transplant Registry. Available at: http://www.fapwtr.org. Accessed September 5, 2006.
6. Stangou AJ, Heaton ND, Hawkins PN. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. NEJM 2005;352:2356.
7. Goto T, Yamashita T, Ueda M, Ohshima S, Yoneyama K, Nakamura M, et al. Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation. AJT 2006;6:2512-2515.
8. Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998;65:918-925.
9. Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000; 123:1495-1504.
10. Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, et al. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl 2003;9:1273-1280.
11. Hornsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Va130Met) patients. Transplantation 2004;78:112-116.